Spiracur, Inc. is a privately held medical device company focused on the development of innovative wound healing technologies.  We are a very passionate group of individuals dedicated to making a difference in patients’ lives in the US and around the world.

Spiracur was founded out of the Stanford BioDesign program in 2007. Spiracur’s first product, The SNaP™ Wound Care System, grew out of the notion that current negative pressure wound therapies were too cumbersome for patients and clinicians. Spiracur strives to develop products that are truly patient-centric.